ABI2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.50730555709333E-12 |
Normal-vs-Stage2 |
1.23040000410413E-08 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62436730732907E-12 |
Stage1-vs-Stage2 |
1.218430E-01 |
Stage1-vs-Stage3 |
5.68269999999815E-05 |
Stage1-vs-Stage4 |
7.43440000006146E-07 |
Stage2-vs-Stage3 |
1.980180E-01 |
Stage2-vs-Stage4 |
1.044780E-01 |
Stage3-vs-Stage4 |
5.286000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
2.43539999944531E-07 |
Normal-vs-Asian |
1.987640E-02 |
Caucasian-vs-AfricanAmerican |
9.394600E-01 |
Caucasian-vs-Asian |
3.067600E-01 |
AfricanAmerican-vs-Asian |
4.694000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.23749899216818E-11 |
Male-vs-Female |
5.954800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.73099999889459E-08 |
Normal-vs-Age(41-60Yrs) |
6.10622663543836E-15 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
3.47350004314961E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.805800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.262800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.989000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.412560E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.637800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.582800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.536000E-01 |
Normal-vs-Grade 2 |
2.74269496003399E-11 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.085590E-01 |
Grade 1-vs-Grade 3 |
1.939730E-02 |
Grade 1-vs-Grade 4 |
5.058400E-03 |
Grade 2-vs-Grade 3 |
1.91553999999705E-05 |
Grade 2-vs-Grade 4 |
6.13289996564959E-09 |
Grade 3-vs-Grade 4 |
6.416000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.51730019846286E-10 |
Normal-vs-ccB subtype |
<1E-12 |
ccA subtype-vs-ccB subtype |
9.56930000000078E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
<1E-12 |
Normal-vs-N1 |
1.60359999723525E-08 |
N0-vs-N1 |
1.987240E-01 |
|
|